Telomir Pharmaceuticals (TELO) Social Media Sentiment and Mentions → the harsh reality of the stock market (From DTI) (Ad) Free TELO Stock Alerts $6.55 -0.72 (-9.90%) (As of 12:15 PM ET) Add Compare Share Share Social MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial Media Media Mentions Over Time1 Last Week 1 Current Week View Trending Media Stocks MarketBeat Searches Over Time0 Last Week 1 Current Week +100.0% Recieve Telomir Pharmaceuticals News and Ratings via Email Sign-up to receive the latest news and ratings for TELO and its competitors with MarketBeat's FREE daily newsletter. Email Address TELO Social Media MentionsAd Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details Related Companies and Tools Related Companies: LFCR Social Sentiment GTHX Social Sentiment GBIO Social Sentiment ZVRA Social Sentiment RIGL Social Sentiment OGI Social Sentiment ACRV Social Sentiment OVID Social Sentiment ATOS Social Sentiment DSGN Social Sentiment Social Media Tools: Trending Media MentionsHigh Media Sentiment StocksTrending WallStreetBets Stocks This page (NASDAQ:TELO) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportProtect Your Bank Account Before It’s Too LateWeiss RatingsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telomir Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
